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background:  No-reflow in ST-segment elevation acute myocardial infarction (STEMI) is associated with a poor clinical prognosis. Its 
pathophysiologal mechanisms are not totally elucidated yet but enhanced vascular permeability plays a key role in this process. Angiopoietin-Like 
4 (ANGPTL4) has been implicated in vascular permeability in experimental models of AMI. We therefore sought to investigate whether baseline 
ANGPTL4 serum levels are associated with no-reflow after primary percutaneous coronary intervention.
methods: A group of 41 consecutive patients with a first STEMI, undergoing successful PPCI within 12h of onset of symptoms were enrolled. Blood 
samples were obtained from all patients on admission for ANGPTL4 levels measurement. No-reflow was assessed by cardiac magnetic resonance 
imaging (MRI), the reference method.
results: MRI-detected no-reflow was observed in 20 patients (48.8%). Variables independently associated with no-reflow at multivariate logistic 
regression analysis were: lower ANGPTL4 plasma levels (odds ratio 0.82, 95% CI 0.70-0.98, P=0.02), higher troponin T peak (odds ratio 1.03, 95% CI 
1.00-1.05, P=0.03), higher incidence of left anterior descending coronary artery as culprit artery (odds ratio 14.61, 95% CI 1.24-172.49, P=0.03), 
and higher C-reactive protein levels (odds ratio 1.18, 95% CI 1.00-1.39, P=0.05).
conclusions: ANGPTL4 serum levels predict MRI-detected no-reflow after successful primary percutaneous coronary intervention in STEMI patients. 
Given the recently demonstrated therapeutic role of ANGPTL4 in diminishing no-reflow and therefore infarct size in pre-clinical animal models, these 
findings in humans may open new fields of research.
